Jupiter Neurosciences Inc (JUNS)

$1.24 -0.05 (-3.88%)
Market Cap 42.70M
Revenue (ttm) 0.00
Net Income (ttm) -2.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 94,200
Avg Vol 634,336
Day's Range N/A - N/A
Shares Out 33.10M
Stochastic %K 40%
Beta N/A
Analysts Sell
Price Target $30.00

Company Profile

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer's disease. It is also involved in t...

Industry: Biotechnology
Sector: Healthcare
Phone: 561 406 6154
Address:
1001 North US Highway 1, Suite 504, Jupiter, United States
benzinga
benzinga Aug. 18 at 5:04 PM
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia™ Brand $JUNS https://www.benzinga.com/partner/biotech/25/08/47183167/longevity-in-a-capsule-jupiter-neurosciences-launches-first-three-supplements-under-nugevia-brand
0 · Reply
Kirisae
Kirisae Aug. 15 at 7:42 AM
$JUNS They have not released earnings! they delayed that! bull trap weak earning coming on monday probably typical biotech scam
1 · Reply
Thenew52
Thenew52 Aug. 14 at 9:58 PM
$JUNS This is not for buying and selling tomorrow or in 3 days, we must hold this stock until we are satisfied with the profits.
0 · Reply
danial88
danial88 Aug. 14 at 4:37 PM
$JUNS Shorts working overtime 🤣
0 · Reply
storkuk
storkuk Aug. 14 at 9:56 AM
$JUNS very weak earning report coming next week! don't get trapped here. after earning report it will fall sharply then would be a good buying point under 1 dollar
1 · Reply
Dani_G_German
Dani_G_German Aug. 13 at 1:23 PM
$JUNS anyone knows their cash position?
0 · Reply
qbtsrycey
qbtsrycey Aug. 11 at 1:42 PM
$JUNS there is news…
1 · Reply
DarthGoat
DarthGoat Aug. 7 at 1:13 PM
$JUNS $LIXT $LRHC $XPOF Starting this morning, I’ll be posting the impressive one-month results of my EPEC calculator every single day. So, since today is August 7, here are the gains you could have made if, on July 7, you had simply placed valid day orders on the tickers and at the prices given by EPEC that day. The green cells indicate which buy orders would have been triggered. All of these prices can be verified on my Substack: https://morningorderswiththegoat.substack.com
0 · Reply
Imr77
Imr77 Aug. 5 at 8:00 AM
$JUNS bounce play 1.3-1.5? until a PR
0 · Reply
Imr77
Imr77 Aug. 4 at 2:30 PM
$JUNS thin volume! does not look good
0 · Reply
Latest News on JUNS
Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jul 23, 2025, 8:00 AM EDT - 26 days ago

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 10, 2025, 4:05 PM EDT - 5 weeks ago

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jun 30, 2025, 3:15 PM EDT - 7 weeks ago

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jun 23, 2025, 8:00 AM EDT - 2 months ago

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Feb 4, 2025, 9:25 AM EST - 6 months ago

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jan 30, 2025, 8:00 AM EST - 7 months ago

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Dec 4, 2024, 4:56 PM EST - 9 months ago

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Dec 2, 2024, 7:00 PM EST - 9 months ago

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

Aug 16, 2022, 5:48 PM EDT - 3 years ago

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

benzinga
benzinga Aug. 18 at 5:04 PM
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia™ Brand $JUNS https://www.benzinga.com/partner/biotech/25/08/47183167/longevity-in-a-capsule-jupiter-neurosciences-launches-first-three-supplements-under-nugevia-brand
0 · Reply
Kirisae
Kirisae Aug. 15 at 7:42 AM
$JUNS They have not released earnings! they delayed that! bull trap weak earning coming on monday probably typical biotech scam
1 · Reply
Thenew52
Thenew52 Aug. 14 at 9:58 PM
$JUNS This is not for buying and selling tomorrow or in 3 days, we must hold this stock until we are satisfied with the profits.
0 · Reply
danial88
danial88 Aug. 14 at 4:37 PM
$JUNS Shorts working overtime 🤣
0 · Reply
storkuk
storkuk Aug. 14 at 9:56 AM
$JUNS very weak earning report coming next week! don't get trapped here. after earning report it will fall sharply then would be a good buying point under 1 dollar
1 · Reply
Dani_G_German
Dani_G_German Aug. 13 at 1:23 PM
$JUNS anyone knows their cash position?
0 · Reply
qbtsrycey
qbtsrycey Aug. 11 at 1:42 PM
$JUNS there is news…
1 · Reply
DarthGoat
DarthGoat Aug. 7 at 1:13 PM
$JUNS $LIXT $LRHC $XPOF Starting this morning, I’ll be posting the impressive one-month results of my EPEC calculator every single day. So, since today is August 7, here are the gains you could have made if, on July 7, you had simply placed valid day orders on the tickers and at the prices given by EPEC that day. The green cells indicate which buy orders would have been triggered. All of these prices can be verified on my Substack: https://morningorderswiththegoat.substack.com
0 · Reply
Imr77
Imr77 Aug. 5 at 8:00 AM
$JUNS bounce play 1.3-1.5? until a PR
0 · Reply
Imr77
Imr77 Aug. 4 at 2:30 PM
$JUNS thin volume! does not look good
0 · Reply
storkuk
storkuk Aug. 4 at 11:26 AM
$JUNS this is doomed! back to 1$
0 · Reply
Imr77
Imr77 Aug. 3 at 8:46 AM
$JUNS I don't quite see the momentum that is needed. maybe a positive PR will do the trick but IMO we need some catalyst before another run!
0 · Reply
Pipio
Pipio Aug. 1 at 11:57 PM
$JUNS we can get close to $3 again next week can we ? 💪🏼💰✅️🚀
0 · Reply
Imr77
Imr77 Aug. 1 at 8:11 AM
$JUNS today might be the last red day! next week can be quite good for JUNS!
0 · Reply
Pharma_Stock_Calls
Pharma_Stock_Calls Jul. 30 at 4:40 PM
✅ 💊 $JUNS Entry: $1.38 → Target: $2.19
0 · Reply
Pharma_Stock_Calls
Pharma_Stock_Calls Jul. 29 at 7:07 PM
✅ 💊 $JUNS Entry: $1.40 → Target: $1.94
0 · Reply
danial88
danial88 Jul. 29 at 3:55 PM
$JUNS WTF!
0 · Reply
Imr77
Imr77 Jul. 25 at 9:13 AM
$JUNS i think it will be bearish for around one more week, then would be a good buy at 1.2 or lower
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 23 at 10:55 PM
$JUNS Brilliant piece that captures JUNS's situation perfectly. So if you want to update your understanding of JUNS or get to know JUNS better, this is essential reading. https://beyondspx.com/article/jupiter-neurosciences-unpacking-the-dual-strategy-powered-by-jotrol-nasdaq-juns
0 · Reply
BioTuesdays
BioTuesdays Jul. 23 at 3:44 PM
Jupiter spotlights critical advancement of JOTROL v conventional resveratrol $JUNS https://biotuesdays.com/2025/07/23/jupiter-spotlights-critical-advancement-of-jotrol-v-conventional-resveratrol/
0 · Reply
movam
movam Jul. 21 at 11:52 PM
$JUNS 2M shares still available to short. Short more.
0 · Reply
Imr77
Imr77 Jul. 21 at 7:10 PM
$JUNS low volume today! not sustainable, will go down in coming days
0 · Reply